Abstract
Eosinophilic colitis is a rare inflammatory bowel disease of unclear origin. It occurs mainly in neonates and in young adults. To date, only one case of treatment in eosinophilic colitis with omalizumab has been described. Here, we present 3 patient cases with eosinophilic colitis which have been treated with omalizumab. Omalizumab is indicated for the treatment of severe allergic asthma and chronic spontaneous urticaria.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
